Thanks to growth in international trade, rapid technological innovation, and a willingness to share intellectual property (IP), the number of corporate cross border alliances has grown steadily.
Carol Cherkis
Advertisement
Carol Cherkis, PhD, is the life science consultant at NewCap Partners.
Articles by Carol Cherkis
Advertisement
Latest Updated Articles
Sharing IP, Sharing RiskPublished: October 1st 2003 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Real-World Data Brings New Insights to Natural History of Disease Studies
2
FDA Approves Hernexeos Under National Priority Voucher Program
3
Pharmaceutical Executive Daily: FDA Approves Palynziq and Sogroya
4
FDA Approves New Indication of Palynziq for Patients 12 Years and Older with Phenylketonuria
5